MS-H Vaccine
Mycoplasma synoviae (live)
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for MS-H Vaccine. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use MS-H Vaccine.
For practical information about using MS-H Vaccine, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
MS-H Vaccine
|
Agency product number |
EMEA/V/C/000161
|
Active substance |
Mycoplasma synoviae strain MS-H
|
International non-proprietary name (INN) or common name |
Mycoplasma synoviae (live)
|
Species |
Chicken
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AE03
|
Publication details | |
---|---|
Marketing-authorisation holder |
Pharmsure Veterinary Products Europe Ltd
|
Revision |
6
|
Date of issue of marketing authorisation valid throughout the European Union |
14/06/2011
|
Contact address |
4 Ormond Quay Upper |
Product information
03/05/2021 MS-H Vaccine - EMEA/V/C/000161 - IAIN/0018
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for aves
-
Live bacterial vaccines
Therapeutic indication
For active immunisation of future broiler breeder chickens, future layer breeder chickens and future layer chickens to reduce air sac lesions and reduce the number of eggs with abnormal shell formation caused by Mycoplasma synoviae.